Hong X, Xu Y, Pang S
J Funct Biomater. 2024; 15(9).
PMID: 39330238
PMC: 11433299.
DOI: 10.3390/jfb15090263.
Hong G, Fu X, Qi J, Shao B, Han X, Fang Y
Fundam Res. 2024; 3(4):557-569.
PMID: 38933554
PMC: 11197514.
DOI: 10.1016/j.fmre.2022.04.016.
Galloni C, Egnuni T, Mohajerani S, Ye J, Mittnacht S, Speirs V
Commun Biol. 2024; 7(1):602.
PMID: 38762624
PMC: 11102446.
DOI: 10.1038/s42003-024-06200-x.
Xie Y, Pan X, Wang Z, Ma H, Xu W, Huang H
J Cancer. 2024; 15(3):776-795.
PMID: 38213730
PMC: 10777041.
DOI: 10.7150/jca.90990.
Xie X, Lu Y, Wang B, Yin X, Chen J
Comb Chem High Throughput Screen. 2023; 27(8):1119-1130.
PMID: 37702239
DOI: 10.2174/1386207326666230912094101.
Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis.
Altaf R, Ilyas U, Ma A, Shi M
Front Oncol. 2023; 13:1206768.
PMID: 37324026
PMC: 10264625.
DOI: 10.3389/fonc.2023.1206768.
Development and validation of a mA -regulated prognostic signature in lung adenocarcinoma.
Chen Y, Xia L, Peng Y, Wang G, Bi L, Xiao X
Front Oncol. 2022; 12:947808.
PMID: 36303829
PMC: 9593055.
DOI: 10.3389/fonc.2022.947808.
Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis.
Otalora-Otalora B, Osuna-Garzon D, Carvajal-Parra M, Canas A, Montecino M, Lopez-Kleine L
Biology (Basel). 2022; 11(7).
PMID: 36101460
PMC: 9313083.
DOI: 10.3390/biology11071082.
DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis.
Lu Y, Yu J, Dong Q, Du Y, Liang Z
Int J Gen Med. 2022; 15:6127-6143.
PMID: 35846794
PMC: 9286484.
DOI: 10.2147/IJGM.S357096.
PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma.
Dong C, Wu K, Gu S, Wang W, Xie S, Zhou Y
Cell Cycle. 2022; 21(13):1406-1421.
PMID: 35323096
PMC: 9345618.
DOI: 10.1080/15384101.2022.2052530.
miR-33b-3p Acts as a Tumor Suppressor by Targeting in Prostate Cancer.
Mei Y, Li K, Zhang Z, Li M, Yang H, Wang H
Front Oncol. 2021; 11:740452.
PMID: 34804930
PMC: 8595470.
DOI: 10.3389/fonc.2021.740452.
The Role of TGF- Signaling Pathways in Cancer and Its Potential as a Therapeutic Target.
Yang Y, Ye W, Zhang R, He X, Wang J, Liu Y
Evid Based Complement Alternat Med. 2021; 2021:6675208.
PMID: 34335834
PMC: 8321733.
DOI: 10.1155/2021/6675208.
deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts.
Xue B, Chuang C, Prosser H, Fuziwara C, Chan C, Sahasrabudhe N
Genes Dev. 2021; 35(15-16):1109-1122.
PMID: 34301766
PMC: 8336896.
DOI: 10.1101/gad.347344.120.
The H3K36me2 writer-reader dependency in H3K27M-DIPG.
Yu J, LeRoy G, Bready D, Frenster J, Saldana-Meyer R, Jin Y
Sci Adv. 2021; 7(29).
PMID: 34261657
PMC: 8279504.
DOI: 10.1126/sciadv.abg7444.
Limited inhibition of multiple nodes in a driver network blocks metastasis.
Yesilkanal A, Yang D, Valdespino A, Tiwari P, Sabino A, Nguyen L
Elife. 2021; 10.
PMID: 33973518
PMC: 8128439.
DOI: 10.7554/eLife.59696.
USP36-Mediated Deubiquitination of DOCK4 Contributes to the Diabetic Renal Tubular Epithelial Cell Injury Wnt/β-Catenin Signaling Pathway.
Zhu S, Hou S, Lu Y, Sheng W, Cui Z, Dong T
Front Cell Dev Biol. 2021; 9:638477.
PMID: 33968925
PMC: 8102983.
DOI: 10.3389/fcell.2021.638477.
Integrative analysis of exosomal microRNA-149-5p in lung adenocarcinoma.
Tian W, Yang H, Zhou B
Aging (Albany NY). 2021; 13(5):7382-7396.
PMID: 33658392
PMC: 7993674.
DOI: 10.18632/aging.202596.
DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer.
Zhao Q, Zhong J, Lu P, Feng X, Han Y, Ling C
PPAR Res. 2021; 2021:6629842.
PMID: 33613670
PMC: 7878079.
DOI: 10.1155/2021/6629842.
WISP1 aggravates cell metastatic potential by abrogating TGF--Smad2/3-dependent epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma.
Song D, Wang L, Su K, Wu H, Li J
Exp Biol Med (Maywood). 2021; 246(11):1244-1252.
PMID: 33593111
PMC: 8371311.
DOI: 10.1177/1535370221992703.
GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway.
Wang J, Xu M, Li D, Abudukelimu W, Zhou X
Open Med (Wars). 2020; 16(1):24-32.
PMID: 33364431
PMC: 7730288.
DOI: 10.1515/med-2021-0011.